| CYSB2100055 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | Supplementary Application | 2021-02-06 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2022-01-27 | view |
| CYSB2100027 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | Supplementary Application | 2021-01-15 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd | Certificate Issued | 2021-09-14 | view |
| JYSB2100033 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(3.4) | Supplementary Application | 2021-01-27 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Certificate Issued | 2021-03-10 | view |
| JYSB2100032 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(3.4) | Supplementary Application | 2021-01-27 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Certificate Issued | 2021-03-10 | view |
| JYSB2100034 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(3.4) | Supplementary Application | 2021-01-27 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Certificate Issued | 2021-03-10 | view |
| JYSB2100035 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(3.4) | Supplementary Application | 2021-01-27 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Certificate Issued | 2021-03-10 | view |
| JYSB2000633 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | Supplementary Application | 2020-12-18 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Filed | 2021-01-05 | view |
| JYSB2000634 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | Supplementary Application | 2020-12-18 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Filed | 2021-01-05 | view |
| JYSB2000636 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | Supplementary Application | 2020-12-18 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Filed | 2021-01-05 | view |
| JYSB2000635 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | Supplementary Application | 2020-12-18 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Filed | 2021-01-05 | view |
| CXSS2000059 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(2.2) | New Drug Application | 2020-12-24 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd | In Review | 2020-12-23 | view |
| JYSZ2000023 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | License Renew | 2020-12-18 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | In Review | 2020-12-16 | view |
| JYSZ2000021 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | License Renew | 2020-12-18 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | In Review | 2020-12-16 | view |
| JYSZ2000022 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | License Renew | 2020-12-18 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | In Review | 2020-12-16 | view |
| JYSZ2000020 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | License Renew | 2020-12-18 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | In Review | 2020-12-16 | view |
| CXSS1900030 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(2) | New Drug Application | 2019-07-01 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2020-10-13 | view |
| JYSB2000454 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(3.1) | Supplementary Application | 2020-09-10 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Filed | 2020-09-18 | view |
| JYSB2000453 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(3.1) | Supplementary Application | 2020-09-10 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Filed | 2020-09-18 | view |
| JYSB2000456 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(3.1) | Supplementary Application | 2020-09-10 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Filed | 2020-09-18 | view |
| JYSB2000455 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(3.1) | Supplementary Application | 2020-09-10 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Filed | 2020-09-18 | view |
